Brief: Algernon Pharmaceuticals Announces Notice Of Allowance For Method Of Use U.S. Patent Application
17/04/2023 12:09
April 17 (Reuters) - Algernon Pharmaceuticals Inc
AGN.CD :
* ALGERNON PHARMACEUTICALS ANNOUNCES NOTICE OF ALLOWANCE FOR
METHOD OF USE U.S. PATENT APPLICATION
Source text for Eikon: ID:nGNX8mHZ1n
Further company coverage: AGN.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grey Matters Health
See all newsBrief: Grey Matters Announces The Closing Of Its Equity And Convertible Debenture Private Placement Totalling CAD $1.12 Million
Brief: Algernon Announces Additional Increase To Private Placement Financing
Brief: Algernon Health Announces Private Placement
Brief: Algernon Announces Closing Of The Private Placement Financing
Brief: Algernon Announces $1 Mln Private Placement